You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0163 Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory rheumatic diseases in daily clinical practice: the experience of cochin hospital, paris, france

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0163 Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory rheumatic diseases in daily clinical practice: the experience of cochin hospital, paris, france
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20173605
Jul 20175403
Aug 20174407
Sep 20174009
Oct 20175004
Nov 20175801
Dec 20175601
Jan 20185803
Feb 20184301
Mar 20183604
Apr 20183400
May 20183200
Jun 20183800
Jul 20181000
Aug 2018400
Sep 2018602
Oct 2018401
Nov 20181206
Dec 2018405
Jan 2019401
Mar 2019506
Apr 2019002
May 2019404
Jun 2019202
Jul 2019602
Aug 20191004
Sep 2019603
Oct 2019202
Nov 2019003
Jan 2020401
Mar 2020602
Apr 2020006
May 2020402
Jun 2020401
Jul 2020601
Aug 2020202
Sep 20201901
Oct 20202003
Nov 20201301
Dec 20201203
Jan 2021602
Feb 20211401
Mar 20211102
Apr 20211401
May 2021805
Jun 2021001
Jul 2021004
Aug 2021003
Sep 2021001
Oct 20210013
Nov 20212014
Dec 2021601
Jan 2022801
Feb 2022201
Mar 2022402
Apr 2022401
May 20228010
Jun 20221603
Jul 20221000
Aug 2022803
Sep 2022206
Oct 2022403
Nov 2022606
Dec 2022401
Jan 20232001
Feb 2023200
Mar 2023800
May 2023003
Jul 2023203
Aug 2023300
Sep 2023001
Oct 2023600
Nov 2023002
Dec 20232000
Jan 2024801
Feb 2024201
Mar 2024207
Total9580208